Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-028270
Filing Date
2025-03-26
Accepted
2025-03-26 16:39:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm258849-3_424b5.htm 424B5 652234
2 GRAPHIC lg_humacyte-4clr.jpg GRAPHIC 17038
  Complete submission text file 0001104659-25-028270.txt   676977
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

EIN.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-267225 | Film No.: 25773820
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)